X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (217) 217
index medicus (171) 171
female (151) 151
dentistry (136) 136
necrosis (131) 131
dentistry, oral surgery & medicine (124) 124
bisphosphonate-associated osteonecrosis of the jaw - diagnostic imaging (123) 123
bones (123) 123
male (123) 123
aged (115) 115
osteonecrosis (104) 104
middle aged (103) 103
diphosphonates - adverse effects (100) 100
bone density conservation agents - adverse effects (98) 98
surgery (77) 77
bisphosphonates (75) 75
risk-factors (74) 74
zoledronic acid (69) 69
jaw (63) 63
aged, 80 and over (61) 61
osteoporosis (61) 61
bisphosphonate-associated osteonecrosis of the jaw - pathology (58) 58
bisphosphonate-related osteonecrosis (55) 55
bisphosphonate (50) 50
bisphosphonate-associated osteonecrosis (49) 49
bisphosphonate-associated osteonecrosis of the jaw - etiology (48) 48
cancer (47) 47
therapy (43) 43
animals (42) 42
retrospective studies (41) 41
denosumab (40) 40
phosphonates (39) 39
risk factors (39) 39
management (38) 38
analysis (36) 36
bone density conservation agents - therapeutic use (36) 36
diphosphonates - therapeutic use (36) 36
adult (35) 35
diphosphonates - administration & dosage (35) 35
prevention (35) 35
bone (34) 34
bone density conservation agents - administration & dosage (34) 34
radiography, panoramic (34) 34
bisphosphonate-associated osteonecrosis of the jaw - diagnosis (33) 33
cancer-patients (33) 33
endocrinology & metabolism (32) 32
care and treatment (31) 31
imidazoles - adverse effects (31) 31
osteonecrosis - chemically induced (30) 30
osteonecrosis of the jaw (30) 30
health aspects (29) 29
osteoporosis - drug therapy (29) 29
radiography (29) 29
american association (28) 28
surgeons position paper (28) 28
tomography, x-ray computed (28) 28
diagnosis (27) 27
jaws (27) 27
bisphosphonate-associated osteonecrosis of the jaw - surgery (26) 26
bisphosphonate-associated osteonecrosis of the jaw - therapy (25) 25
mandible - diagnostic imaging (25) 25
radiology, nuclear medicine & medical imaging (24) 24
bronj (23) 23
diphosphonates (23) 23
treatment outcome (23) 23
medicine & public health (22) 22
orthopedics (22) 22
rats (22) 22
bone neoplasms - drug therapy (21) 21
jaw diseases - chemically induced (21) 21
mandible (21) 21
multiple-myeloma (21) 21
oncology (21) 21
tooth extraction (21) 21
disease models, animal (20) 20
bisphosphonate-associated osteonecrosis of the jaw (19) 19
drug therapy (19) 19
medication-related osteonecrosis (19) 19
case-control studies (18) 18
mandibular diseases - diagnostic imaging (18) 18
pamidronate (18) 18
bisphosphonate-associated osteonecrosis of the jaw - complications (17) 17
bisphosphonate-associated osteonecrosis of the jaw - drug therapy (17) 17
computed tomography (17) 17
cone-beam computed tomography (17) 17
imaging findings (17) 17
metastasis (17) 17
x-ray microtomography (17) 17
alendronate (16) 16
bisphosphonate-related osteonecrosis of the jaw (16) 16
bone neoplasms - secondary (16) 16
diagnosis, differential (16) 16
imidazoles - administration & dosage (16) 16
mandible - pathology (16) 16
otorhinolaryngology (16) 16
research (16) 16
association (15) 15
bone density (15) 15
drugs (15) 15
medical research (15) 15
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (257) 257
French (3) 3
German (2) 2
Japanese (2) 2
Arabic (1) 1
Hungarian (1) 1
Spanish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of bone and mineral research, ISSN 0884-0431, 2015, Volume 30, Issue 1, pp. 3 - 23
This work provides a systematic review of the literature from January 2003 to April 2014 pertaining to the incidence, pathophysiology, diagnosis, and treatment of osteonecrosis of the jaw (ONJ... 
OSTEONECROSIS OF THE JAW | DIAGNOSIS | BISPHOSPHONATES | MANAGEMENT | RISK FACTORS | DENOSUMAB | IMAGING | TREATMENT | Treatment | Imaging | Osteonecrosis of the jaw | Diagnosis | Management | Denosumab | Bisphosphonates | Risk factors | SINGLE-CENTER EXPERIENCE | BONE-MINERAL DENSITY | BEAM COMPUTED-TOMOGRAPHY | RANDOMIZED CONTROLLED-TRIAL | CROSS-LINKING TELOPEPTIDE | COMPARING ZOLEDRONIC ACID | MULTIPLE-MYELOMA PATIENTS | BISPHOSPHONATE-RELATED OSTEONECROSIS | ENDOCRINOLOGY & METABOLISM | BREAST-CANCER PATIENTS | SURGEONS POSITION PAPER | Humans | Osteoporosis - diagnosis | Osteoporosis - drug therapy | Mandible - diagnostic imaging | Monocytes - immunology | Cone-Beam Computed Tomography | Bisphosphonate-Associated Osteonecrosis of the Jaw - immunology | Mandible - immunology | Bacterial Infections - immunology | Bisphosphonate-Associated Osteonecrosis of the Jaw - diagnostic imaging | Osteoporosis - diagnostic imaging | Monocytes - pathology | Diphosphonates - therapeutic use | T-Lymphocytes - pathology | Diphosphonates - adverse effects | Macrophages - immunology | Antibodies, Monoclonal, Humanized - adverse effects | Antibodies, Monoclonal, Humanized - therapeutic use | Osteoporosis - immunology | Macrophages - pathology | Risk Factors | Receptors, Antigen, T-Cell, gamma-delta - immunology | Consensus | Bisphosphonate-Associated Osteonecrosis of the Jaw - diagnosis | Bisphosphonate-Associated Osteonecrosis of the Jaw - therapy | T-Lymphocytes - immunology | Bisphosphonate-Associated Osteonecrosis of the Jaw - etiology | Care and treatment | Bacterial infections | Platelet-derived growth factor | Corticosteroids | Diagnostic imaging | Transplantation | T cells | Necrosis | Osteoporosis | Toiletries industry | Stem cells | Bones | Health aspects | Scanning devices
Journal Article
Journal Article
British Journal of Oral and Maxillofacial Surgery, ISSN 0266-4356, 2014, Volume 52, Issue 7, pp. 603 - 608
Journal Article
Journal of bone and mineral research, ISSN 1523-4681, 2015, Volume 30, Issue 9, pp. 1627 - 1640
ABSTRACT Osteonecrosis of the jaws (ONJ) is a significant complication of antiresorptive medications, such as bisphosphonates and denosumab... 
ZOLEDRONIC ACID | ALVEOLAR BONE | BISPHOSPHONATES | OSTEOCLASTS | DENOSUMAB | OSTEONECROSIS OF THE JAW (ONJ) | ANTIRESORPTIVES | alveolar bone | antiresorptives | zoledronic acid | osteoclasts | bisphosphonates | denosumab | osteonecrosis of the jaw (ONJ) | RISK-FACTORS | INDUCE OSTEONECROSIS | NITROGEN-CONTAINING BISPHOSPHONATES | BONE-RESORPTION | POSTMENOPAUSAL OSTEOPOROSIS | CANCER-PATIENTS | CLINICAL-APPLICATIONS | BISPHOSPHONATE-RELATED OSTEONECROSIS | ENDOCRINOLOGY & METABOLISM | EXPERIMENTAL PERIODONTITIS | KAPPA-B LIGAND | RANK Ligand - metabolism | Recombinant Fusion Proteins - pharmacology | Tartrate-Resistant Acid Phosphatase | Male | Mandible - diagnostic imaging | X-Ray Microtomography | Acid Phosphatase - metabolism | Isoenzymes - metabolism | Diphosphonates - therapeutic use | Disease Models, Animal | Bone Resorption | Maxilla - diagnostic imaging | Mice, Inbred C57BL | Osteoprotegerin - pharmacology | Abscess | Rats | Imidazoles - pharmacology | Osteoclasts - metabolism | Animals | RANK Ligand - antagonists & inhibitors | Bisphosphonate-Associated Osteonecrosis of the Jaw - pathology | Immunoglobulin Fc Fragments - pharmacology | Mice | Denosumab - pharmacology | Bisphosphonate-Associated Osteonecrosis of the Jaw - drug therapy | Diphosphonates - pharmacology | Osteoporosis | Bones | Phosphonates | Necrosis | Animal models | Zoledronic acid | Mandibles | Osteonecrosis | Acid phosphatase (tartrate-resistant) | TRANCE protein | Acid phosphatase | Bisphosphonates | Osteoprotegerin | Metastases
Journal Article
Journal of bone and mineral research, ISSN 0884-0431, 2016, Volume 31, Issue 8, pp. 1596 - 1607
...) are often utilized in RA patients to reduce bone destruction and manage osteoporosis. However, BPs, especially at high doses, are associated with osteonecrosis of the jaw (ONJ... 
BISPHOSPHONATES | COLLAGEN‐INDUCED ARTHRITIS | OSTEOCLASTS | RHEUMATOID ARTHRITIS | OSTEONECROSIS OF THE JAWS | ONJ | ANTIRESORPTIVE | Antiresorptive | Osteonecrosis of the jaws | Collagen-induced arthritis | Rheumatoid arthritis | Osteoclasts | Onj | Bisphosphonates | COLLAGEN-INDUCED ARTHRITIS | RISK-FACTORS | INDUCE OSTEONECROSIS | NECROSIS-FACTOR-ALPHA | PERIAPICAL DISEASE | ZOLEDRONIC ACID | POSTMENOPAUSAL OSTEOPOROSIS | BISPHOSPHONATE-RELATED OSTEONECROSIS | ENDOCRINOLOGY & METABOLISM | TARGETING OSTEOCLASTS | BONE DESTRUCTION | Maxilla - drug effects | Mandible - pathology | Male | Mandible - diagnostic imaging | Arthritis, Rheumatoid - complications | X-Ray Microtomography | Arthritis, Rheumatoid - diagnostic imaging | Arthritis, Rheumatoid - drug therapy | Bisphosphonate-Associated Osteonecrosis of the Jaw - diagnostic imaging | Mandible - drug effects | Diphosphonates - therapeutic use | Mice, Inbred DBA | Imidazoles - therapeutic use | Imaging, Three-Dimensional | Maxilla - pathology | Severity of Illness Index | Maxilla - diagnostic imaging | Imidazoles - pharmacology | Zoledronic Acid | Disease Progression | Arthritis, Rheumatoid - pathology | Animals | Bisphosphonate-Associated Osteonecrosis of the Jaw - pathology | Bisphosphonate-Associated Osteonecrosis of the Jaw - etiology | Bisphosphonate-Associated Osteonecrosis of the Jaw - drug therapy | Diphosphonates - pharmacology | Rheumatoid factor | Osteoporosis | Collagen | Analysis | Bones | Arthritis | Necrosis | Knee | Synovitis | Jaw | Animal models | Mandible | Visual cortex | Collagen (type II) | Osteonecrosis | Bone (trabecular) | Joint diseases | Cartilage | Periodontal ligament | Computed tomography | Thinning | Freund's adjuvant | Rodents | Mandibles | Zoledronic acid | Bone loss | Bone (cortical) | osteoclasts | antiresorptive | bisphosphonates | rheumatoid arthritis | osteonecrosis of the jaws
Journal Article
Osteoporosis International, ISSN 0937-941X, 3/2017, Volume 28, Issue 3, pp. 1145 - 1147
...CASE REPORT Osteonecrosis of the jaw (ONJ) and atypical femoral fracture (AFF) in an osteoporotic patient chronically treated with bisphosphonates A. Sánchez 1... 
Osteoporosis | Treatment | Medicine & Public Health | Complications | Subtrochanteric atypical fractures | Orthopedics | Rheumatology | Drug-induced osteonecrosis of the jaw | Bisphosphonates | Endocrinology | ENDOCRINOLOGY & METABOLISM | Bone Density Conservation Agents - adverse effects | Drug Administration Schedule | Fractures, Spontaneous - diagnostic imaging | Humans | Imidazoles - adverse effects | Imidazoles - administration & dosage | Diphosphonates - administration & dosage | Bone Density Conservation Agents - administration & dosage | Osteoporosis, Postmenopausal - drug therapy | Radiography | Alendronate - adverse effects | Fractures, Spontaneous - chemically induced | Bisphosphonate-Associated Osteonecrosis of the Jaw - diagnostic imaging | Aged, 80 and over | Hip Fractures - diagnostic imaging | Female | Bisphosphonate-Associated Osteonecrosis of the Jaw - etiology | Drug Therapy, Combination | Diphosphonates - adverse effects | Alendronate - administration & dosage | Hip Fractures - chemically induced | Care and treatment | Parathyroid hormone | Bones | Research | Health aspects | Backache | Risk factors | Necrosis | Jaw | Femur | Back pain | Low back pain | Calcitriol | Osteonecrosis | Alendronic acid | Calcium (blood) | Pain | Analgesics | Calcitonin | Zoledronic acid | Densitometry | Dual energy X-ray absorptiometry | Mandible | Teeth | Hip | Calcium phosphates | Fractures | Magnetic resonance imaging | Antibiotics | Collagen | Geriatrics | Cancer
Journal Article
Journal of Cranio-Maxillo-Facial Surgery, ISSN 1010-5182, 2016, Volume 44, Issue 10, pp. 1689 - 1693
Journal Article